Nuvation Bio
NUVB
117 hedge funds and large institutions have $837M invested in Nuvation Bio in 2022 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 37 increasing their positions, 36 reducing their positions, and 7 closing their positions.
171% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 7
11% more funds holding
Funds holding: 105 → 117 (+12)
1.66% more ownership
Funds ownership: 71.35% → 73.01% (+1.7%)
3% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 36
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
37% less capital invested
Capital invested by funds: $1.32B → $837M (-$483M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BG
Baupost Group
Boston,
Massachusetts
|
+$10.2M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$9.39M |
| 3 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$8.26M |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$6.49M |
| 5 |
6CM
683 Capital Management
New York
|
+$5.81M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$14.2M |
| 2 |
PA
Perceptive Advisors
New York
|
-$6.47M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$6.19M |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$4.25M |
| 5 |
CAC
Cowen and Company
New York
|
-$3.06M |
NUVB Hedge Fund Activity: Q1 2022 in Review
117 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Nuvation Bio (NUVB) for Q1 2022, worth a combined $837M — down 37% from $1.32B a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new NUVB positions and 7 closed out — a net gain of 12 holders — while 37 added to existing stakes and 36 trimmed.
The largest buyer was Baupost Group, adding an estimated $10.2M. The largest seller was Avidity Partners Management, cutting an estimated $14.2M.
- 117 institutional investors held Nuvation Bio (NUVB) as of Q1 2022, up from 105 in Q4 2021.
- Funds reported $837M of Nuvation Bio stock for Q1 2022, down 37% quarter-over-quarter.
- 19 funds opened new Nuvation Bio positions in Q1 2022 and 7 closed out, a net change of +12 holders.
- The largest Nuvation Bio buyer in Q1 2022 was Baupost Group, an estimated $10.2M added.
- The largest Nuvation Bio seller in Q1 2022 was Avidity Partners Management, an estimated $14.2M sold.
Based on aggregated 13F filings for Q1 2022.